Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $2.2B bought by 561 insiders at 349 companies
- $9.4B sold by 702 insiders outside a trading plan
- $5.4B sold by 990 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past 3 months · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
RSGRepublic Services, Inc.Cascade Investment, L.l.c.10% owner · +1 joint filer$454M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$179M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$158M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$74.4M
-
FTKFlotek Industries, Inc.Matthew WilksDirector$34.3M
-
PAMTPamt Corp.Matthew T MorounDirector$31.2M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
Biggest sales
Past 3 months · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
NVDANvidia Corporation ComMark A StevensDirector$536M
-
INGMIngram Micro Holding CorporationPlatinum Equity, LLC10% owner · +9 joint filers$410M
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
SNOWSnowflake Inc.Frank SlootmanDirector$283M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
CHYMChime Financial, Inc.DST Global Advisors Ltd10% owner · +9 joint filers$237M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
-
LFSTLifeStance Health Group, Inc.Tpg Gp A, LLC10% owner · +2 joint filers$226M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Che-Chia Wei CEO, Yung-Pei Chin COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more
-
Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Todd C. Skinner President, InternationalTRUTransUnionPlanned sale$62K 1,000 shares at $62.29 1.8% of stakeTraded Oct 1 Filed Oct 2
-
Mohamed Abdelsadek EVP, Chief Global SolutionsTRUTransUnionPlanned sale$16K 250 shares at $62.29 0.5% of stakeTraded Oct 1 Filed Oct 2
-
David Joseph Gaffin EVP, CLO, Alkermes, Inc.ALKSAlkermes plcPlanned sale$83K 2,034 shares at $41.03 0.9% of stakeTraded Oct 2 Filed Oct 2
-
Brian Michael Brown Chief Legal OfficerAVPTAvePoint, Inc.Planned sale$141K 10,000 shares at $14.11 2.7% of stakeTraded Sep 30 Filed Oct 2
-
Ita M Brennan DirectorPLPlanet Labs PBCPlanned sale$187K 11,500 shares at $16.30 4.4% of stakeTraded Oct 1 Filed Oct 2
-
Frances Arnold DirectorGOOGLAlphabet Inc., Class APlanned sale$28K 83 shares at $340.45 0.4% of stakeTraded Sep 30 Filed Oct 2
-
Gregory L Hendry Chief Accounting OfficerPMTPennyMac Mortgage Investment TrustPlanned sale$19K 2,444 shares at $7.86 33% of stakeTraded Oct 1 Filed Oct 2
-
Gregory Baszucki DirectorRBLXRoblox CorporationPlanned sale$714K 16,666 shares at $42.87 1.3% of stakeTraded Oct 1 Filed Oct 2
-
Jon Congleton CEOMLYSMineralys Therapeutics, Inc.Planned sale$1.9M 75,000 shares at $25.46 12% of stakeTraded Sep 30 Filed Oct 2
-
Michael John Callahan Chief Administrative OfficerRIVNRivian Automotive, Inc.Planned sale$225K 15,000 shares at $15.00 1.5% of stakeTraded Oct 1 Filed Oct 2
-
Richard A. Heyman DirectorORICOric Pharmaceuticals, Inc.Planned sale$87K 6,700 shares at $12.91Traded Oct 1 Filed Oct 2
-
John Wendell Thompson DirectorRBRKRubrik, Inc.Planned sale$1.6M 13,500 shares at $115.69Traded Oct 1 Filed Oct 2
-
Scott Bender CEOWHDCactus, Inc.Planned sale$6.2M 100,000 shares at $61.97 45% of stakeTraded Oct 1 Filed Oct 2
-
Markus Gloeckler Chief Technology OfficerFSLRFirst Solar, Inc.Planned sale$139K 800 shares at $174.00 14% of stakeTraded Oct 1 Filed Oct 2
-
Hollings Renton DirectorANABAnaptysBio, Inc.Planned sale$249K 5,000 shares at $49.87 31% of stakeTraded Oct 1 Filed Oct 2
-
Eric Venker CEOROIVRoivant Sciences Ltd.Planned sale$7.3M 200,000 shares at $36.62 11% of stakeTraded Sep 30 Filed Oct 2
-
Jonathan Allan General Counsel & Corp SecSTOKStoke Therapeutics, Inc.Planned sale$17K 627 shares at $26.33 3% of stakeTraded Oct 2 Filed Oct 2
-
Barry Ticho Chief Medical OfficerSTOKStoke Therapeutics, Inc.Planned sale$27K 1,051 shares at $26.16 5.2% of stakeTraded Oct 1 Filed Oct 2
-
Daniel J Bartlett Executive Vice PresidentWMTWalmart Inc.Planned sale$417K 3,990 shares at $104.41 0.6% of stakeTraded Oct 1 Filed Oct 2
-
Amit Gupta CEOCDLXCardlytics, Inc.Sale$47K 17,733 shares at $2.64 11% of stakeTraded Oct 1–2 Filed Oct 2
-
Christine Ring Chief Legal OfficerNRIXNurix Therapeutics, Inc.Planned sale$134K 5,786 shares at $23.19 39% of stakeTraded Oct 2 Filed Oct 2
-
Glenn Steele Jr. MD PHD DirectorPTCTPTC Therapeutics, Inc.Planned sale$782K 12,000 shares at $65.16 35% of stakeTraded Sep 30 Filed Oct 2
-
Adam C. Spice CFORKLBRocket Lab CorporationPlanned sale$9.9M 140,157 shares at $70.82 11% of stakeTraded Oct 1 Filed Oct 2
-
Raymond Woo Chief Technology OfficerCBLLCeriBell, Inc.Planned sale$119K 4,887 shares at $24.38 2.3% of stakeTraded Oct 1 Filed Oct 2
-
Avraham Gabay CFOORMPOramed Pharmaceuticals Inc.Planned sale$90K 20,000 shares at $4.51 2.3% of stakeTraded Oct 1 Filed Oct 2
-
Joshua Hexter COOORMPOramed Pharmaceuticals Inc.Planned sale$135K 30,000 shares at $4.51 2.2% of stakeTraded Oct 1 Filed Oct 2
-
Dan Paterson CEOVSTMVerastem, Inc.Planned sale$353K 44,121 shares at $8.00 6.3% of stakeTraded Oct 1 Filed Oct 2
-
Daniel Calkins CFOVSTMVerastem, Inc.Planned sale$21K 2,566 shares at $8.00 2% of stakeTraded Oct 1 Filed Oct 2
-
Gregory M. Hart CEOCOURCoursera, Inc.Planned sale$53K 10,308 shares at $5.11 0.7% of stakeTraded Oct 1 Filed Oct 2
-
Aaron Jagdfeld CEOGNRCGenerac Holdings Inc.Planned sale$1M 5,000 shares at $206.00 0.9% of stakeTraded Oct 1 Filed Oct 2
-
Jeffrey Jacob Raider DirectorWRBYWarby Parker Inc.Planned sale$416K 15,000 shares at $27.70 3.4% of stakeTraded Oct 1 Filed Oct 2
-
Neil Harris Blumenthal CEOWRBYWarby Parker Inc.Planned sale$2.8M 100,000 shares at $27.69 74% of stakeTraded Oct 1 Filed Oct 2
-
Joseph Stilwell Director · +5 joint filersWHLRWheeler Real Estate Investment Trust, Inc.Sale$15 5 shares at $3.03 <0.1% of stakeTraded Sep 30 Filed Oct 2
-
Peter McNamara Chief Scientific OfficerTECXTectonic Therapeutic, Inc.Planned sale$12K 536 shares at $23.04 1% of stakeTraded Sep 30 Filed Oct 2
-
Aman Joshi Chief Commercial OfficerBEBloom Energy CorporationPlanned sale$2.3M 8,437 shares at $277.17 5.4% of stakeTraded Oct 1 Filed Oct 2
-
Yat Tung Lam COOCRDOCredo Technology Group Holding LtdPlanned sale$10.3M 50,000 shares at $205.22 2.2% of stakeTraded Oct 1 Filed Oct 2
-
Michelle F. Link Chief of Human ResourcesMMSMaximus, Inc.Planned sale$174K 3,208 shares at $54.23 19% of stakeTraded Oct 1 Filed Oct 2
-
Thomas C Indelicarto EVP, Gen Counsel & SecretaryVRSNVerisign Inc.Planned sale$142K 500 shares at $284.38 1.5% of stakeTraded Oct 1 Filed Oct 2
-
Steven Pieper See RemarksXERSXeris Biopharma Holdings, Inc.Planned sale$47K 5,000 shares at $9.41 0.4% of stakeTraded Oct 1 Filed Oct 2
-
Kevin McCulloch See RemarksXERSXeris Biopharma Holdings, Inc.Planned sale$141K 15,000 shares at $9.41 0.9% of stakeTraded Oct 1 Filed Oct 2
-
Beth Hecht See RemarksXERSXeris Biopharma Holdings, Inc.Planned sale$157K 16,666 shares at $9.41 1.5% of stakeTraded Oct 1 Filed Oct 2
-
Timothy Pierce Morningstar EVP, Chief Growth OfficerBJBJ's Wholesale Club Holdings, Inc.Sale$457K 4,856 shares at $94.09 13% of stakeTraded Oct 1 Filed Oct 2
-
William C. Werner EVP, Strategy & DevelopmentBJBJ's Wholesale Club Holdings, Inc.Sale$285K 3,000 shares at $95.00 5.6% of stakeTraded Oct 1 Filed Oct 2
-
Mark J. Darling Chief Retail OfficerHRBH&R Block, Inc.Sale$110K 2,700 shares at $40.69 11% of stakeTraded Sep 30 Filed Oct 2
-
Eric Stokes SVP and Group President of WTSNWPXNWPX Infrastructure, Inc.Planned sale$1.3M 12,353 shares at $103.38 33% of stakeTraded Oct 1 Filed Oct 2
-
Sudhir Gopalswamy Group President, AMG & ISGONON Semiconductor CorporationPlanned sale$1.2M 15,578 shares at $80.00 9% of stakeTraded Oct 1 Filed Oct 2
-
William Marshall Mauney Jr. Vice President, R&DPOWLPowell Industries, Inc.Sale$56K 301 shares at $187.67 2.8% of stakeTraded Sep 30 Filed Oct 2
-
Daniel Patrick O'Day CEOGILDGilead Sciences Inc.Planned sale$2.2M 15,000 shares at $147.90 2.6% of stakeTraded Oct 1 Filed Oct 2
-
Matthew L. Posard DirectorHALOHalozyme Therapeutics, Inc.Planned sale$568K 5,230 shares at $108.54 8.9% of stakeTraded Oct 1 Filed Oct 2
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.